Journals / Retina-Vitreus / 2015 / Cilt: 23 - Sayı: 0

Central Serous Chorioretinopathy in IVF Induced Pregnancy

İn Vitro Fertilizasyon Sonrası Gebelikte SantralSeröz Koryoretinopati

Pages
155–157
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In our case we wanted to emphasize that IVF induced pregnancy may put more emotional stress and aggravate central serous chorioretinopathy

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A previously healthy 36 weeks pregnant woman with decreased vision in the left eye was referred to our clinic.
📊
Key Findings & Data:Her full ophthalmologic examination revealed elevation at the left macula and optical coherence tomographic examination confirmed cetral serous chorioretinopathy.
💡
Conclusion & Impact:In our case we wanted to emphasize that IVF induced pregnancy may put more emotional stress and aggravate central serous chorioretinopathy
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A previously healthy 36 weeks pregnant woman with decreased vision in the left eye was referred to our clinic. Her full ophthalmologic examination revealed elevation at the left macula and optical coherence tomographic examination confirmed cetral serous chorioretinopathy. Three months after the labor the symptoms and the clinical findings resolved spontaneously without a clinical intervention. In her anamnesis, it is ascertained that pregnancy was induced by in vitro fertilization (IVF). In our case we wanted to emphasize that IVF induced pregnancy may put more emotional stress and aggravate central serous chorioretinopathy

Özet

Bilinen hiçbir sistemik hastalığı olmayan 36 haftalık gebe hasta 3 haftadır süren sol gözde görme azlığı şikayeti ile kliniğimize başvurdu. Hastanın yapılan tam oftalmolojik muayenesinde sol makülada elevasyon tespit edildi ve optik koherens tomografisi sonrasında santral seröz koryoretinopati tanısı doğrulandı. Hastanın takiplerinde gebelik sonrası 3. ay muayenesinde şikayetleri ve klinik bulguları kendiliğinden tamamen düzeldi ve bir tıbbi tedavi gerekmedi. Hastanın anamnezinde in vitro fertilizasyon (İVF) yöntemiyle stres altında gebe kaldığı tespit edildi. Olgumuzda İVF sonrası sağlanmış bir gebeliğin hastada yaratacağı emosyonel stresin santral seröz korioretinopati gelişimini artabileceğini vurgulamak istedik

🔖

Cite This Article

ÇOBAN, M. K., YAYCIOĞLU, R. A., Burak, U. (2015). Central Serous Chorioretinopathy in IVF Induced Pregnancy. Retina-Vitreus, Cilt: 23 - Sayı: 0, 155–157. https://ajindex.com/articles/304987

References (9)

  1. Gass JDM. Stereoscopic atlas of macular diseases; diagnosis and treat- ment, 4th edn, vol 1. Mosby, St Louis, 1997;52-70.
  2. Chumbley LC, Frank RN. Central serous retinopathy and pregnancy. Arch Ophthalmol 1974;109:677-81.
  3. Sunnuess JS, Haller JA, Fine SL Central serous chorioretinopathy and pregnancy. Arch Ophthalmol 1993;111:360-4.
  4. Liew G, Quin G, Gillies M et al. Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Experiment Ophthal- mol 2013;41:201-14.
  5. Taner P, Akarsu C. Gebeliğin göz üzerindeki etkileri. Ret-vit 2001;9:169- 78. Errera MH, Kohly RP, da Cruz L. Pregnancy-associated retinal diseases and their management. Surv Ophthalmol 2013;58:127-42.
  6. Arslanpençe A, Batıoğlu F. Gebelikte retina, koroid ve optik sinir pa- tolojileri T Klin Oftalmol 2000; 9:211-8.
  7. Haimovici R, Koh S, Gagnon DR, et al. Central serous chorioretinopa- thy Case-Control Study Group. Risk factors for central serous chorio- retinopathy. Ophthalmology 2004;111:244-9.
  8. Khaled S.A, Gamal M, Medhat F. Incidence and natural course of symp- tomatic central serous chorioretinopathy in pregnant women in a mater- nity hospital in Kuwait. Middle East Afr J Ophthalmol 2012;19:273-6.
  9. Rezai KA, Eliot D. Optical coherence tomographic findings in pregnan- cy-associated central serous chorioretinopathy. Graefe's Arch Clin Exp Ophthalmol 2004;242:1014-6.